https://www.thebodypro.com/article/dolutegravir-monotherapy-still-no-longer-recommend
Dolutegravir (Tivicay)Conference Coverage

Dolutegravir Monotherapy: Still No Longer Recommended in Either Research or Clinical Practice

    Simon Collins

    HIV i-Base

    HIV i-Base